Stay updated on Pembrolizumab in Lymphoma Subtypes Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Lymphoma Subtypes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Lymphoma Subtypes Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added the Maryland location under Locations and updated the page revision to v3.3.3. Removed the Maryland Locations footer item and the HHS Vulnerability Disclosure link.
    Difference
    0.2%
    Check dated 2025-12-23T07:55:22.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:36:00.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T12:43:20.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Removed the notice about operating status due to a lapse in government funding from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:21:46.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots; the page content and layout appear unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T00:58:54.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Updated core content: added government operating status notice, added a new malignant lymphoma term, and updated revision to v3.2.0; removed an older lymphoma classification and earlier revision v3.1.0.
    Difference
    2%
    Check dated 2025-10-05T08:31:30.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Lymphoma Subtypes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Lymphoma Subtypes Clinical Trial page.